Patient and family costs associated with tuberculosis, including multidrug-resistant tuberculosis, in Ecuador.

Resumen

Direct and indirect costs borne by patients with active TB and their families are very high in Ecuador, and are highest for patients with MDR-TB. These costs are important barriers to treatment completion.